0.0500
0.0000
(0.00%)
At close: April 9 at 10:25:44 AM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
--
--
--
94.3680
13.3330
Gross Profit
--
--
--
94.3680
13.3330
Operating Expense
675.8820
675.8820
561.2320
671.0800
410.8760
Operating Income
-675.8820
-675.8820
-561.2320
-576.7120
-397.5430
Net Non Operating Interest Income Expense
16.3600
16.3600
13.2600
0.6360
0.8570
Other Income Expense
1,714.8090
1,714.8090
-9,619.8900
--
5
Pretax Income
1,055.2870
1,055.2870
-10,167.8620
-576.0760
-391.6860
Net Income Common Stockholders
1,055.2870
1,055.2870
-10,167.8620
-576.0760
-391.6860
Basic EPS
0.00
--
-0.04
-0.00
-0.00
Diluted EPS
0.00
--
-0.04
-0.00
-0.00
Basic Average Shares
316,459.4040
--
281,846.3540
281,846.3540
246,132.0680
Diluted Average Shares
316,459.4040
--
281,846.3540
281,846.3540
246,132.0680
Net Income from Continuing & Discontinued Operation
1,055.2870
1,055.2870
-10,167.8620
-576.0760
-391.6860
Normalized Income
1,055.2870
1,055.2870
-10,167.8620
-576.0760
-391.6860
Interest Income
16.3600
16.3600
13.2600
0.6360
0.8570
Net Interest Income
16.3600
16.3600
13.2600
0.6360
0.8570
EBIT
-675.8820
-675.8820
-561.2320
-576.7120
-397.5430
EBITDA
-675.8820
-675.8820
-561.2320
-576.7120
-397.5430
Net Income from Continuing Operation Net Minority Interest
1,055.2870
1,055.2870
-10,167.8620
-576.0760
-391.6860
Normalized EBITDA
-675.8820
-675.8820
-561.2320
-576.7120
-397.5430
6/30/2021 - 8/27/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
TRP.AX Tissue Repair Ltd
0.2350
-4.08%
CMB.AX Cambium Bio Limited
0.2800
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
ATX.AX Amplia Therapeutics Limited
0.0520
-7.14%
MEM.AX Memphasys Limited
0.0070
0.00%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%